Bio Farma

Bio Farma is a state-owned enterprise in Indonesia that specializes in the production of vaccines and sera to support public health initiatives both domestically and internationally. Established in 1890, originally as Parc Vaccinogène, Bio Farma has played a pivotal role in the eradication and control of infectious diseases in Indonesia and is a key player in the global vaccine industry.

History[edit | edit source]

Bio Farma's journey began in the late 19th century when it was founded to address the rabies epidemic in Bandung, Java. Over the years, it expanded its portfolio to include vaccines for smallpox, diphtheria, tetanus, and other diseases. Following Indonesia's independence, the company was nationalized and renamed Bio Farma. It has since grown into one of the largest vaccine manufacturers in the world, with its products reaching more than 140 countries.

Products and Services[edit | edit source]

Bio Farma produces a wide range of vaccines and sera, including but not limited to, polio, diphtheria, tetanus, pertussis, hepatitis B, and measles. The company is also involved in research and development activities to create new vaccines and improve existing ones. Bio Farma's commitment to quality and safety has earned it certifications from various international health organizations, including the World Health Organization (WHO).

Global Contributions[edit | edit source]

Bio Farma is a key contributor to global health initiatives, particularly in the developing world. It is a member of the Developing Countries Vaccine Manufacturers Network (DCVMN), through which it collaborates with other manufacturers to increase access to affordable vaccines. Bio Farma has also played a significant role in the Global Polio Eradication Initiative, supplying millions of doses of polio vaccine to countries in need.

Challenges and Future Directions[edit | edit source]

Despite its successes, Bio Farma faces challenges such as competition from global pharmaceutical giants, the need for continuous innovation, and the complexities of vaccine distribution in low-resource settings. The company is investing in research and development, expanding its production capacity, and exploring new technologies such as mRNA vaccines to address these challenges.

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Translate this page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.